Journalartikel
Autorenliste: Lange, Uwe; Reuss-Borst, Monika
Jahr der Veröffentlichung: 2017
Seiten: 217-221
Zeitschrift: Aktuelle Rheumatologie
Bandnummer: 42
Heftnummer: 3
ISSN: 0341-051X
eISSN: 1438-9940
DOI Link: https://doi.org/10.1055/s-0042-114978
Verlag: Georg Thieme Verlag
Abstract:
Laboratory tests are an important tool in the diagnostic and differential diagnostic investigation of osteologic diseases. As recommended in the German S3 guideline for osteoporosis, a basic laboratory examination is essential for the differentiation between primary and secondary osteoporosis, and of prime importance for initiating an appropriate treatment. Markers of bone turnover may provide additional information regarding the dynamics of bone metabolism. They are mainly used to guide the choice of treatment and the monitoring of treatment response and patient compliance after the initiation of an anti-osteoporosis therapy. This paper aims to describe the significance of the established osteologic laboratory tests for metabolic bone diseases in everyday practice.
Zitierstile
Harvard-Zitierstil: Lange, U. and Reuss-Borst, M. (2017) Laboratory Analysis in Metabolic Bone Diseases: Possibilities and Limitations, Aktuelle Rheumatologie, 42(3), pp. 217-221. https://doi.org/10.1055/s-0042-114978
APA-Zitierstil: Lange, U., & Reuss-Borst, M. (2017). Laboratory Analysis in Metabolic Bone Diseases: Possibilities and Limitations. Aktuelle Rheumatologie. 42(3), 217-221. https://doi.org/10.1055/s-0042-114978
Schlagwörter
ALENDRONATE; BIOCHEMICAL MARKERS; FRACTURE INTERVENTION TRIAL; general basic laboratory examinations; INTERINDIVIDUAL VARIATION; markers of bone turnover (bone biomarkers); POSTMENOPAUSAL WOMEN; RESORPTION MARKERS; TURNOVER; ZOLEDRONIC ACID